The role of leukotriene modifiers in the treatment of asthma

Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1363-71. doi: 10.1164/ajrccm.157.5.9706059.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Asthma / drug therapy*
  • Asthma / etiology
  • Asthma / physiopathology
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / analogs & derivatives
  • Hydroxyurea / therapeutic use
  • Indoles
  • Leukotriene Antagonists*
  • Leukotrienes / physiology
  • Lipoxygenase Inhibitors / adverse effects
  • Lipoxygenase Inhibitors / therapeutic use
  • Phenylcarbamates
  • Sulfonamides
  • Tosyl Compounds / adverse effects
  • Tosyl Compounds / therapeutic use

Substances

  • Indoles
  • Leukotriene Antagonists
  • Leukotrienes
  • Lipoxygenase Inhibitors
  • Phenylcarbamates
  • Sulfonamides
  • Tosyl Compounds
  • zileuton
  • Hydroxyurea
  • zafirlukast